SCHEMBL17075751

SCHEMBL17075751

NN1CC=NC=C1c1ccc(-c2ccc(C(F)(F)F)cc2C(=O)N2CCS(=O)(=O)CC2)cc1F

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 17/20 0.67
FEN1 P39748 17/20 0.67
SLC6A9 P48067 2/20 0.39
SCN9A Q15858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15916366 0.80 ALOX5AP (1.00) ALOX5APFEN1
SCHEMBL15915736 0.79 FEN1 (1.00) ALOX5APFEN1
SCHEMBL17075748 0.78 ALOX5AP (0.62) ALOX5APFEN1SLC6A9SCN9A
SCHEMBL17075746 0.75 ALOX5AP (0.57) ALOX5APFEN1SLC6A9SCN9A
SCHEMBL15915734 0.71 FEN1 (0.86) ALOX5APFEN1
SCHEMBL20627559 0.69 ALOX5AP (0.77) ALOX5APFEN1
SCHEMBL15915900 0.68 ALOX5AP (1.00) ALOX5APFEN1
SCHEMBL14440752 0.68 ALOX5AP (0.55) ALOX5APFEN1SCN9A
SCHEMBL15918106 0.67 ALOX5AP (1.00) ALOX5APFEN1
SCHEMBL20627567 0.67 FEN1 (0.77) ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R ALOX5AP 80/4885FEN1 2/4885SLC6A9 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.